Close Menu

This article has been updated with additional information from Roche's earnings call. 

NEW YORK (GenomeWeb) – Roche on Thursday reported a 3 percent increase in sales of its diagnostics division in 2019, driven primarily by its immunodiagnostic solutions, which are part of its Centralized and Point of Care Solutions business.

Overall, Roche reported CHF 61.47 billion ($63.4 billion) in revenues for the year, up 9 percent at constant exchange rates from CHF 56.85 billion in 2018.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.